Aurora Labs（0FR）株式概要Aurora Labs Limitedは、オーストラリアで3Dメタルプリンター、デジタルパーツ、関連知的財産の設計、開発、製造、商品化に従事している。 詳細0FR ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性3/6配当金0/6リスク分析過去1年間で株主の希薄化は大幅に進んだ 収益が 100 万ドル未満 ( A$708K )German市場と比較して、過去 3 か月間の株価の変動が非常に大きいキャッシュランウェイが1年未満である +1 さらなるリスクすべてのリスクチェックを見る0FR Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.019726.1% 割高 内在価値ディスカウントEst. Revenue$PastFuture-8m4m2016201920222025202620282031Revenue AU$4.3mEarnings AU$401.0kAdvancedSet Fair ValueView all narrativesAurora Labs Limited 競合他社SCHUMAGSymbol: DB:SCMMarket cap: €11.2mXomaSymbol: DB:QM8Market cap: €7.0mDATRONSymbol: XTRA:DARMarket cap: €38.9mAlexanderwerkSymbol: DB:ALXAMarket cap: €45.4m価格と性能株価の高値、安値、推移の概要Aurora Labs過去の株価現在の株価AU$0.0352週高値AU$0.0552週安値AU$0.0005ベータ0.471ヶ月の変化-11.59%3ヶ月変化24.49%1年変化-18.67%3年間の変化205.00%5年間の変化-36.72%IPOからの変化-98.54%最新ニュースBoard Change • May 21Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). Executive Director of Strategy & Strategic Partnerships and Executive Director Andrew Garth is the most experienced director on the board, commencing their role in 2024. Independent Non- Executive Director Andrew Bottrell was the last independent director to join the board, commencing their role in 2026. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.お知らせ • Oct 14Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 59,602,251 Price\Range: AUD 0.052 Discount Per Security: AUD 0.00312 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 46,166,980 Price\Range: AUD 0.052 Discount Per Security: AUD 0.00312 Transaction Features: Subsequent Direct Listingお知らせ • Oct 09Aurora Labs Limited, Annual General Meeting, Nov 17, 2025Aurora Labs Limited, Annual General Meeting, Nov 17, 2025.New Risk • Nov 17New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (31% average weekly change). Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (AU$174k revenue, or US$112k). Minor Risk Market cap is less than US$100m (€18.3m market cap, or US$19.3m).お知らせ • Nov 06Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 26,666,667 Price\Range: AUD 0.075 Discount Per Security: AUD 0.00375 Transaction Features: Subsequent Direct Listingお知らせ • Sep 24Aurora Labs Limited, Annual General Meeting, Nov 14, 2024Aurora Labs Limited, Annual General Meeting, Nov 14, 2024.最新情報をもっと見るRecent updatesBoard Change • May 21Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). Executive Director of Strategy & Strategic Partnerships and Executive Director Andrew Garth is the most experienced director on the board, commencing their role in 2024. Independent Non- Executive Director Andrew Bottrell was the last independent director to join the board, commencing their role in 2026. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.お知らせ • Oct 14Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 59,602,251 Price\Range: AUD 0.052 Discount Per Security: AUD 0.00312 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 46,166,980 Price\Range: AUD 0.052 Discount Per Security: AUD 0.00312 Transaction Features: Subsequent Direct Listingお知らせ • Oct 09Aurora Labs Limited, Annual General Meeting, Nov 17, 2025Aurora Labs Limited, Annual General Meeting, Nov 17, 2025.New Risk • Nov 17New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (31% average weekly change). Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (AU$174k revenue, or US$112k). Minor Risk Market cap is less than US$100m (€18.3m market cap, or US$19.3m).お知らせ • Nov 06Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 26,666,667 Price\Range: AUD 0.075 Discount Per Security: AUD 0.00375 Transaction Features: Subsequent Direct Listingお知らせ • Sep 24Aurora Labs Limited, Annual General Meeting, Nov 14, 2024Aurora Labs Limited, Annual General Meeting, Nov 14, 2024.Reported Earnings • Aug 23Full year 2024 earnings released: AU$0.01 loss per share (vs AU$0.014 loss in FY 2023)Full year 2024 results: AU$0.01 loss per share (improved from AU$0.014 loss in FY 2023). Net loss: AU$2.81m (loss narrowed 5.3% from FY 2023). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.お知らせ • May 01Aurora Labs Limited, Annual General Meeting, May 30, 2024Aurora Labs Limited, Annual General Meeting, May 30, 2024, at 10:00 W. Australia Standard Time. Location: 41-43 Wittenberg Drive, Canning Vale, Western Australia Canning Vale Western Australia Australia Agenda: To consider the Ratification of Placement Shares pursuant to Listing Rule 7.1; to consider the Issue of Placement Options; to consider the Issue of Placement Shares and Placement Options to Mr Grant Mooney; and to consider other matters.お知らせ • Apr 23Aurora Labs Limited has filed a Follow-on Equity Offering in the amount of AUD 2.04 million.Aurora Labs Limited has filed a Follow-on Equity Offering in the amount of AUD 2.04 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 65,166,667 Price\Range: AUD 0.03 Discount Per Security: AUD 0.0018 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,833,333 Price\Range: AUD 0.03 Discount Per Security: AUD 0.0018 Security Features: Attached Options Transaction Features: Subsequent Direct ListingNew Risk • Feb 25New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (38% average weekly change). Revenue is less than US$1m (AU$220k revenue, or US$144k). Market cap is less than US$10m (€4.92m market cap, or US$5.32m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding).お知らせ • Dec 22Aurora Labs Limited ORDINARY FULLY PAID to Be Deleted from OTC EquityAurora Labs Limited ORDINARY FULLY PAID (Australia) will be deleted from OTC Equity effective December 21, 2023, due to Inactive Security.お知らせ • Nov 29Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 0.9416 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 0.9416 million. Security Name: Ortdinary Shares Security Type: Common Stock Securities Offered: 35,800,000 Price\Range: AUD 0.022 Security Name: Ortdinary Shares Security Type: Common Stock Securities Offered: 7,000,000 Price\Range: AUD 0.022 Transaction Features: Subsequent Direct ListingNew Risk • Nov 29New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (47% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Revenue is less than US$1m (AU$135k revenue, or US$89k). Market cap is less than US$10m (€4.43m market cap, or US$4.87m).New Risk • Nov 28New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (46% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Revenue is less than US$1m (AU$135k revenue, or US$89k). Market cap is less than US$10m (€3.90m market cap, or US$4.28m).お知らせ • Oct 27Aurora Labs Limited, Annual General Meeting, Nov 29, 2023Aurora Labs Limited, Annual General Meeting, Nov 29, 2023, at 09:00 W. Australia Standard Time. Location: HLB Mann Judd, Level 4, 130 Stirling Street Perth, Western Australia Western Australia Australia Agenda: To consider the Annual Report of the Company and its controlled entities for the year ended 30 June 2023, which includes the Financial Report, the Directors' Report and the Auditor's Report; to consider remuneration report; to consider re-election of director; and to consider other matters.Reported Earnings • Aug 27Full year 2023 earnings released: EPS: AU$0.014 (vs AU$0.018 loss in FY 2022)Full year 2023 results: EPS: AU$0.014 (up from AU$0.018 loss in FY 2022). Net loss: AU$2.96m (loss narrowed 5.9% from FY 2022). Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.Board Change • Apr 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Chairman & Company Secretary Grant Mooney was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 24First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.011 loss in 1H 2022)First half 2023 results: AU$0.009 loss per share (improved from AU$0.011 loss in 1H 2022). Net loss: AU$1.69m (loss narrowed 4.9% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 26Full year 2022 earnings released: AU$0.018 loss per share (vs AU$0.031 loss in FY 2021)Full year 2022 results: AU$0.018 loss per share (up from AU$0.031 loss in FY 2021). Net loss: AU$3.15m (loss narrowed 29% from FY 2021). Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 50% per year, which means it is significantly lagging earnings.Recent Insider Transactions • Apr 15Founder & CTO recently sold €211k worth of stockOn the 14th of April, David Budge sold around 3m shares on-market at roughly €0.074 per share. This was the largest sale by an insider in the last 3 months. David has been a seller over the last 12 months, reducing personal holdings by €372k.Reported Earnings • Aug 28Full year 2021 earnings released: AU$0.03 loss per share (vs AU$0.079 loss in FY 2020)Full year 2021 results: Net loss: AU$4.42m (loss narrowed 46% from FY 2020). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 34% per year, which means it is significantly lagging earnings.Recent Insider Transactions • Aug 03Founder & CTO recently sold €140k worth of stockOn the 29th of July, David Budge sold around 2m shares on-market at roughly €0.057 per share. This was the largest sale by an insider in the last 3 months. David has been a seller over the last 12 months, reducing personal holdings by €649k.株主還元0FRDE MachineryDE 市場7D69.4%3.3%2.8%1Y-18.7%-0.6%1.4%株主還元を見る業界別リターン: 0FR過去 1 年間で-0.6 % の収益を上げたGerman Machinery業界を上回りました。リターン対市場: 0FR過去 1 年間で1.4 % の収益を上げたGerman市場を上回りました。価格変動Is 0FR's price volatile compared to industry and market?0FR volatility0FR Average Weekly Movement89.3%Machinery Industry Average Movement5.3%Market Average Movement6.0%10% most volatile stocks in DE Market12.8%10% least volatile stocks in DE Market2.7%安定した株価: 0FRの株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 0FRの weekly volatility ( 89% ) は過去 1 年間安定していますが、依然としてGermanの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト201413Rebekah Lethebywww.auroralabs3d.comAurora Labs Limitedは、オーストラリアで3Dメタルプリンター、デジタルパーツ、関連知的財産の設計、開発、製造、商品化に従事している。産業用3D金属プリンターを開発。同社はエネルギー、鉱業、インフラ、公共事業、防衛分野にサービスを提供している。オーロラ・ラボ・リミテッドは2014年に法人化され、オーストラリアのカニングベールに拠点を置く。もっと見るAurora Labs Limited 基礎のまとめAurora Labs の収益と売上を時価総額と比較するとどうか。0FR 基礎統計学時価総額€18.01m収益（TTM）-€2.49m売上高(TTM)€434.98k41.4xP/Sレシオ-7.2xPER（株価収益率0FR は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計0FR 損益計算書（TTM）収益AU$708.31k売上原価AU$338.60k売上総利益AU$369.72kその他の費用AU$4.42m収益-AU$4.05m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.0077グロス・マージン52.20%純利益率-572.18%有利子負債／自己資本比率0.9%0FR の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 23:00終値2026/05/27 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Aurora Labs Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Board Change • May 21Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). Executive Director of Strategy & Strategic Partnerships and Executive Director Andrew Garth is the most experienced director on the board, commencing their role in 2024. Independent Non- Executive Director Andrew Bottrell was the last independent director to join the board, commencing their role in 2026. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
お知らせ • Oct 14Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 59,602,251 Price\Range: AUD 0.052 Discount Per Security: AUD 0.00312 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 46,166,980 Price\Range: AUD 0.052 Discount Per Security: AUD 0.00312 Transaction Features: Subsequent Direct Listing
お知らせ • Oct 09Aurora Labs Limited, Annual General Meeting, Nov 17, 2025Aurora Labs Limited, Annual General Meeting, Nov 17, 2025.
New Risk • Nov 17New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (31% average weekly change). Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (AU$174k revenue, or US$112k). Minor Risk Market cap is less than US$100m (€18.3m market cap, or US$19.3m).
お知らせ • Nov 06Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 26,666,667 Price\Range: AUD 0.075 Discount Per Security: AUD 0.00375 Transaction Features: Subsequent Direct Listing
お知らせ • Sep 24Aurora Labs Limited, Annual General Meeting, Nov 14, 2024Aurora Labs Limited, Annual General Meeting, Nov 14, 2024.
Board Change • May 21Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). Executive Director of Strategy & Strategic Partnerships and Executive Director Andrew Garth is the most experienced director on the board, commencing their role in 2024. Independent Non- Executive Director Andrew Bottrell was the last independent director to join the board, commencing their role in 2026. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
お知らせ • Oct 14Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 59,602,251 Price\Range: AUD 0.052 Discount Per Security: AUD 0.00312 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 46,166,980 Price\Range: AUD 0.052 Discount Per Security: AUD 0.00312 Transaction Features: Subsequent Direct Listing
お知らせ • Oct 09Aurora Labs Limited, Annual General Meeting, Nov 17, 2025Aurora Labs Limited, Annual General Meeting, Nov 17, 2025.
New Risk • Nov 17New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (31% average weekly change). Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (AU$174k revenue, or US$112k). Minor Risk Market cap is less than US$100m (€18.3m market cap, or US$19.3m).
お知らせ • Nov 06Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 26,666,667 Price\Range: AUD 0.075 Discount Per Security: AUD 0.00375 Transaction Features: Subsequent Direct Listing
お知らせ • Sep 24Aurora Labs Limited, Annual General Meeting, Nov 14, 2024Aurora Labs Limited, Annual General Meeting, Nov 14, 2024.
Reported Earnings • Aug 23Full year 2024 earnings released: AU$0.01 loss per share (vs AU$0.014 loss in FY 2023)Full year 2024 results: AU$0.01 loss per share (improved from AU$0.014 loss in FY 2023). Net loss: AU$2.81m (loss narrowed 5.3% from FY 2023). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
お知らせ • May 01Aurora Labs Limited, Annual General Meeting, May 30, 2024Aurora Labs Limited, Annual General Meeting, May 30, 2024, at 10:00 W. Australia Standard Time. Location: 41-43 Wittenberg Drive, Canning Vale, Western Australia Canning Vale Western Australia Australia Agenda: To consider the Ratification of Placement Shares pursuant to Listing Rule 7.1; to consider the Issue of Placement Options; to consider the Issue of Placement Shares and Placement Options to Mr Grant Mooney; and to consider other matters.
お知らせ • Apr 23Aurora Labs Limited has filed a Follow-on Equity Offering in the amount of AUD 2.04 million.Aurora Labs Limited has filed a Follow-on Equity Offering in the amount of AUD 2.04 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 65,166,667 Price\Range: AUD 0.03 Discount Per Security: AUD 0.0018 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,833,333 Price\Range: AUD 0.03 Discount Per Security: AUD 0.0018 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
New Risk • Feb 25New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (38% average weekly change). Revenue is less than US$1m (AU$220k revenue, or US$144k). Market cap is less than US$10m (€4.92m market cap, or US$5.32m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding).
お知らせ • Dec 22Aurora Labs Limited ORDINARY FULLY PAID to Be Deleted from OTC EquityAurora Labs Limited ORDINARY FULLY PAID (Australia) will be deleted from OTC Equity effective December 21, 2023, due to Inactive Security.
お知らせ • Nov 29Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 0.9416 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 0.9416 million. Security Name: Ortdinary Shares Security Type: Common Stock Securities Offered: 35,800,000 Price\Range: AUD 0.022 Security Name: Ortdinary Shares Security Type: Common Stock Securities Offered: 7,000,000 Price\Range: AUD 0.022 Transaction Features: Subsequent Direct Listing
New Risk • Nov 29New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (47% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Revenue is less than US$1m (AU$135k revenue, or US$89k). Market cap is less than US$10m (€4.43m market cap, or US$4.87m).
New Risk • Nov 28New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (46% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Revenue is less than US$1m (AU$135k revenue, or US$89k). Market cap is less than US$10m (€3.90m market cap, or US$4.28m).
お知らせ • Oct 27Aurora Labs Limited, Annual General Meeting, Nov 29, 2023Aurora Labs Limited, Annual General Meeting, Nov 29, 2023, at 09:00 W. Australia Standard Time. Location: HLB Mann Judd, Level 4, 130 Stirling Street Perth, Western Australia Western Australia Australia Agenda: To consider the Annual Report of the Company and its controlled entities for the year ended 30 June 2023, which includes the Financial Report, the Directors' Report and the Auditor's Report; to consider remuneration report; to consider re-election of director; and to consider other matters.
Reported Earnings • Aug 27Full year 2023 earnings released: EPS: AU$0.014 (vs AU$0.018 loss in FY 2022)Full year 2023 results: EPS: AU$0.014 (up from AU$0.018 loss in FY 2022). Net loss: AU$2.96m (loss narrowed 5.9% from FY 2022). Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.
Board Change • Apr 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Chairman & Company Secretary Grant Mooney was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 24First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.011 loss in 1H 2022)First half 2023 results: AU$0.009 loss per share (improved from AU$0.011 loss in 1H 2022). Net loss: AU$1.69m (loss narrowed 4.9% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 26Full year 2022 earnings released: AU$0.018 loss per share (vs AU$0.031 loss in FY 2021)Full year 2022 results: AU$0.018 loss per share (up from AU$0.031 loss in FY 2021). Net loss: AU$3.15m (loss narrowed 29% from FY 2021). Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 50% per year, which means it is significantly lagging earnings.
Recent Insider Transactions • Apr 15Founder & CTO recently sold €211k worth of stockOn the 14th of April, David Budge sold around 3m shares on-market at roughly €0.074 per share. This was the largest sale by an insider in the last 3 months. David has been a seller over the last 12 months, reducing personal holdings by €372k.
Reported Earnings • Aug 28Full year 2021 earnings released: AU$0.03 loss per share (vs AU$0.079 loss in FY 2020)Full year 2021 results: Net loss: AU$4.42m (loss narrowed 46% from FY 2020). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 34% per year, which means it is significantly lagging earnings.
Recent Insider Transactions • Aug 03Founder & CTO recently sold €140k worth of stockOn the 29th of July, David Budge sold around 2m shares on-market at roughly €0.057 per share. This was the largest sale by an insider in the last 3 months. David has been a seller over the last 12 months, reducing personal holdings by €649k.
